To Compare the Efficacy of Harmal capsule versus Methi capsule in the Managment of Primary dysmenorrhea (Kashtartava)

Comparative Evaluation of Efficacy of Harmal (Peganum harmala Linn.) capsule versus Methi (Trigonella foenum-graecum Linn.) capsule in the management of Primary dysmenorrhea (Kashtartava); A randomized control trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071499

Enrollment

Registered

2024-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Unmarried women between the age of 16 and 30 years old. Patient willing to participate with Written informed consent. Female patients who have experienced pain during their periods for more than two months in a row.

Exclusion criteria

Exclusion criteria: Women less then16 years and above 30 years Women with any pelvic pathology and irregular periods. Patients with a history of other health problems that might affect the treatment process.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Harmal capsule in the management of Primary dysmenorrhea (kashtartav)Timepoint: 3 consecutive cycle	—

Secondary

Measure	Time frame
To compare the efficacy of Harmala seeds churna capsule versus Methi seeds churna capsule on Primary Dysmenorrhea (Kashtartava)Timepoint: 3 consecutive cycle	—

Countries

India

Contacts

Public ContactDr Jaimala Annasaheb Jadhav

Mahatma Gandhi Ayurved College Salod Wardha

jaymalajadhav0610@gmail.com9922190843

Outcome results